April 2024

Newest lupus drug in 60 years discovered in Canada, approved in USA

Lupus Canada is pleased to learn of the recent FDA approval of Lupkynis. While it is very exciting that new medications are being approved in the United States, with over 1 in 1000 Canadians living with lupus there is not enough treatment options within Canada. Being the only national organization dedicated to lupus research, advocacy, public awareness and patient support, we work to ensure all Canadian lupus patients have easy and equitable access to lupus specific medications.  Lupus Canada strongly urges the Government of Canada to approve more options for lupus drugs like Lupkynis to better support Canadians living with lupus. A made in Canada treatment to lupus, must be available to Canadians living with lupus.

Lupus Blog Articles: Lupus lorem ipsum dolor sit amet est requiem deste natur.

Anifrolumab (Saphnelo) listed in SK


Belimumab (Benlysta) listed in AB, NL & NIHB


Belimumab (Benlysta) listed in ON